Categories: Business

F.D.A. Clears Another Coronavirus Testing Kit for Use at Home

The Food and Drug Administration on Saturday granted emergency clearance for a coronavirus testing kit that will enable individuals to take a nasal sample at home and send it to a laboratory for diagnostic testing, the second such approval it has made.

Dr. Jeffrey Shuren, director of the agency’s Center for Devices and Radiological Health, said in a statement that the new test “not only provides increased patient access to tests, but also protects others from potential exposure.” Health care workers can risk infection when they administer diagnostic tests.

The kit, made by Everlywell, will contain a swab for individuals to use to take a sample from inside the nostrils, and a tube filled with a saline solution to put it in for sending to one of two private lab companies: Fulgent Therapeutics or Assurance Scientific Laboratories. The company plans to partner with additional laboratories.

Some public health researchers have warned that at-home nasal swab tests can be less accurate than the specimen collection performed by health care providers, which involves inserting a long nasal swab through the nose into the back of the throat.

Christina Song, an Everlywell spokeswoman, said consumers will first take an online screening survey to determine whether they meet federal guidelines for the test. The survey will be reviewed quickly by health care providers affiliated with PWNHealth, the company’s telemedicine partner. If a consumer qualifies for the test, one will be shipped out immediately.

“From the moment that you hit the order button, to the moment that you get the test results on your phone or device, that process is designed to take three to five days,” Ms. Song said.

The test kits will be available later this month, according to Ms. Song, and will cost $135.

In announcing its authorization for the Everlywell testing kit, the F.D.A. said the company had “leveraged” data from studies supported by the Bill and Melinda Gates Foundation and UnitedHealth Group to show that the specimens would stay stable during shipping.

Everlywell makes a variety of products that individuals can buy online or in stores, among them at-home test kits for diabetes, sexually transmitted diseases and high cholesterol.

Some of the company’s products, such as those purporting to test for food sensitivities, have come under criticism. Everlywell was also one of several businesses that drew attention from members of Congress in March for entering the market for coronavirus test kits in March without F.D.A. approval.

Everlywell, which had promoted its at-home kit as a consumer product, said in a statement at the time that it had not sold any of the kits to consumers, but was providing the test materials “at cost to hospitals and health care organizations who can commit to providing the test for free to their workers and patients.”

Jerry Rolon

After working for 7 years as a Internet Marketer, Jerry now aims to explore the journalistic side of Internet. With his impeccable knowledge in this domain, he churns out some of the best news articles from the internet niche. With respect to acedamics, Jerry earned a degree in business from California State University.

Recent Posts

Sandford Blair Capital Poised to Capitalize on Oracle’s AI-Cloud Breakthrough

Oracle’s Fiscal Q1 2026: A Landmark Quarter Lier, Flanders, 12th September 2025, ZEX PR WIRE,…

1 day ago

Countdown to Forex Expo Dubai 2025 – Your Chance to Take Home the Jetour X70 FL

Just Weeks Away From the Middle East’s Leading Trading Event, Returning October 6–7 at Dubai…

1 day ago

Dogecoin Pops As First U.S. Memecoin ETF Eyes Friday Debut

Dogecoin (DOGE) extended weekly gains as traders positioned for the REX-Osprey Dogecoin ETF (ticker: DOJE),…

2 days ago

World AI Show Returns to Kuala Lumpur with MDEC as Strategic Partner.

Kuala Lumpur, Malaysia, 12th September 2025, ZEX PR WIRE, The World AI Show is back…

2 days ago

The King Maker, Anonymous Collective, Claims to Solve Blockchain’s Impossible Randomness Problem

Lisbon, Portugal, 11th September 2025, ZEX PR WIRE, EvaCodes, a European software development house, has…

2 days ago

SOL surges past $210. Quid Miner cloud mining brings investors a stable daily income of $5,000.

New Hampshire, USA, 11th September 2025, ZEX PR WIRE, In September 2025, Solana (SOL) sparked…

2 days ago